Product analysis
Alpha GPC 300 mg offers a focused choline-related ingredient with preliminary attention and cognitive-support evidence. Unspecified active-content details limit how confidently the declared serving can be matched to that evidence.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
The alpha-GPC preparation and active-content basis are not specified. That makes equivalence with precisely defined preparations uncertain.
Ingredient Transparency63
The declared amount permits a basic serving comparison. Missing preparation detail leaves uncertainty about the active-content basis behind that amount.
Value For Money100
The declared serving compares favorably on cost. Unverified active-content detail limits how directly that price can be compared with precisely specified preparations.
Customer Satisfaction87
Ratings show positive satisfaction across a large number of responses. The broad response provides a more established picture of satisfaction without establishing cognitive effects.
Product Focus53
The single ingredient keeps the formula centered on choline-related brain functions. Attention and cognitive evidence remains preliminary and tied to specific preparations and short-term testing.
- Format
Capsule - Container
- 60 Capsule(s)
- Per serving
- $0.79
- Customer rating
- 4.6 · 6,118 ratings
Goals
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Alpha GPC | 600 mg |
How this ingredient is rated
Active Ingredient Quality & Bioavailability70
Patented/Branded Form and Source
Dose, Safety & Label Transparency80
Active Alpha-GPC Dosage
Label Transparency & Yield Disclosure
Value100
Price per 300mg Active Alpha-GPC
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis.
- Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial.
- Effects of choline alfoscerate on cognitive function and quality of life in type 2 diabetes: A double-blind, randomized, placebo-controlled trial.
- Acute Alpha-Glycerylphosphorylcholine Supplementation Enhances Cognitive Performance in Healthy Men.
- Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.
- [Gliatilin in the Treatment of Cognitive Impairments Not Reaching the Level of Dementia: Meta-Analysis and Systematic Review].
- Vertical Association Between Dietary Total Choline and L-alpha-glycerylphosphorylcholine and the Cognitive Function in Chinese Adults Aged over 55, Result from China Health and Nutrition Survey 1997-2018.
- Treatment of dementia with neurotransmission modulation.